NVST
Price
$19.81
Change
-$0.22 (-1.10%)
Updated
Jul 15 closing price
Capitalization
3.67B
15 days until earnings call
PRPH
Price
$0.42
Change
-$0.01 (-2.33%)
Updated
Jul 15 closing price
Capitalization
116.75M
22 days until earnings call
Interact to see
Advertisement

NVST vs PRPH

Header iconNVST vs PRPH Comparison
Open Charts NVST vs PRPHBanner chart's image
Envista Holdings
Price$19.81
Change-$0.22 (-1.10%)
Volume$2.1M
Capitalization3.67B
ProPhase Labs
Price$0.42
Change-$0.01 (-2.33%)
Volume$425.97K
Capitalization116.75M
NVST vs PRPH Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. PRPH commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and PRPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (NVST: $19.81 vs. PRPH: $0.42)
Brand notoriety: NVST and PRPH are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVST: 97% vs. PRPH: 16%
Market capitalization -- NVST: $3.67B vs. PRPH: $116.75M
NVST [@Medical Specialties] is valued at $3.67B. PRPH’s [@Medical Specialties] market capitalization is $116.75M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whilePRPH’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • PRPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both NVST and PRPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 3 TA indicator(s) are bullish while PRPH’s TA Score has 4 bullish TA indicator(s).

  • NVST’s TA Score: 3 bullish, 5 bearish.
  • PRPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRPH is a better buy in the short-term than NVST.

Price Growth

NVST (@Medical Specialties) experienced а -1.69% price change this week, while PRPH (@Medical Specialties) price change was -5.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

PRPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.00% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.67B) has a higher market cap than PRPH($117M). NVST has higher P/E ratio than PRPH: NVST (21.74) vs PRPH (17.01). NVST YTD gains are higher at: 2.696 vs. PRPH (-45.053). NVST has higher annual earnings (EBITDA): 171M vs. PRPH (-9.64M). NVST has more cash in the bank: 940M vs. PRPH (3.27M). PRPH has less debt than NVST: PRPH (18.9M) vs NVST (1.65B). NVST has higher revenues than PRPH: NVST (2.57B) vs PRPH (62.7M).
NVSTPRPHNVST / PRPH
Capitalization3.67B117M3,135%
EBITDA171M-9.64M-1,774%
Gain YTD2.696-45.053-6%
P/E Ratio21.7417.01128%
Revenue2.57B62.7M4,094%
Total Cash940M3.27M28,773%
Total Debt1.65B18.9M8,751%
FUNDAMENTALS RATINGS
NVST vs PRPH: Fundamental Ratings
NVST
PRPH
OUTLOOK RATING
1..100
2032
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4450
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (50) in the null industry is in the same range as PRPH (50) in the Household Or Personal Care industry. This means that NVST’s stock grew similarly to PRPH’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as PRPH (100) in the Household Or Personal Care industry. This means that NVST’s stock grew similarly to PRPH’s over the last 12 months.

NVST's SMR Rating (100) in the null industry is in the same range as PRPH (100) in the Household Or Personal Care industry. This means that NVST’s stock grew similarly to PRPH’s over the last 12 months.

NVST's Price Growth Rating (44) in the null industry is in the same range as PRPH (50) in the Household Or Personal Care industry. This means that NVST’s stock grew similarly to PRPH’s over the last 12 months.

NVST's P/E Growth Rating (100) in the null industry is in the same range as PRPH (100) in the Household Or Personal Care industry. This means that NVST’s stock grew similarly to PRPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTPRPH
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
67%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TADGX82.61N/A
N/A
T. Rowe Price Dividend Growth Advisor
ASIRX11.16N/A
N/A
Alger Small Cap Growth Institutional R
AUUCX20.50N/A
N/A
AB Select US Equity C
AEMSX14.99N/A
N/A
abrdn Emerging Markets Instl Svc
KGGAX15.34N/A
N/A
Kopernik Global All-Cap A

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with ALGN. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-1.10%
ALGN - NVST
65%
Loosely correlated
-3.26%
A - NVST
56%
Loosely correlated
-5.95%
MTD - NVST
56%
Loosely correlated
-2.12%
XRAY - NVST
55%
Loosely correlated
-0.50%
ICUI - NVST
53%
Loosely correlated
-3.33%
More

PRPH and

Correlation & Price change

A.I.dvisor tells us that PRPH and FLGT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and FLGT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
-2.16%
FLGT - PRPH
29%
Poorly correlated
-5.49%
NVST - PRPH
29%
Poorly correlated
-1.10%
ANIP - PRPH
28%
Poorly correlated
-1.83%
ICCM - PRPH
27%
Poorly correlated
-1.94%
MTD - PRPH
27%
Poorly correlated
-2.12%
More